Organization: Health Canada
Year: 2025
Month: February
Request Number: A-2021-001974
Request Summary: Provide the Screening acceptance letter(s) from Health Canada to any and all generic drug manufacturers for any and all Abbreviated New Drug Submissions (ANDS) for the medicinal ingredient dexlansoprazole which appears on the list of Generic Drug Submissions Under Review (GSUR).
Disposition: Disclosed in part
Number of pages: 1